Skip to main content

K Yonemori

First name:
K
Last name:
Yonemori
Fukase, Y. ., Sato, A. ., Tomata, Y. ., Ochida, A. ., Kono, M. ., Yonemori, K. ., … Yamamoto, S. . (2017). Identification of novel quinazolinedione derivatives as RORγt inverse agonist. Bioorganic & Medicinal Chemistry. https://doi.org/10.1016/j.bmc.2017.12.039 (Original work published 2017)
Amano, Y. ., Yamakawa, H. ., Yonemori, K. ., Shimada, M. ., & Tozawa, R. . (2017). Farnesoid X receptor antagonist exacerbates dyslipidemia in mice. Pharmacological Reports : PR, 70(1), 172-177. https://doi.org/10.1016/j.pharep.2017.07.010 (Original work published 2017)
Fujiwara, Y. ., Kenmotsu, H. ., Yamamoto, N. ., Shimizu, T. ., Yonemori, K. ., Ocampo, C. ., … Murakami, H. . (2021). Phase 1 study of telisotuzumab vedotin in Japanese patients with advanced solid tumors. Cancer Medicine, 10(7), 2350-2358. https://doi.org/10.1002/cam4.3815